Judith James, MD
Enriched profileExecutive Vice President & Chief Medical Officer · Oklahoma Medical Research Foundation
Judith James is Executive Vice President & Chief Medical Officer at Oklahoma Medical Research Foundation. OpenAlex indexes 576 publications with 28,508 citations (h-index 86); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Judith James, MD, PHD, is Executive Vice President & Chief Medical Officer at Oklahoma Medical Research Foundation. The public record shows 576 publications with 28,508 citations (h-index 86), centered on Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 4 companies, 27 NIH-funded awards (1991–2026).
- Most recent indexed publication: 2026 · Arthritis care & research
- Top research focus: Systemic Lupus Erythematosus Research
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 44 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 319.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
Sponsor: University of Oklahoma
- COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations
Sponsor: University of Oklahoma
Industry payments
Updated 27 Aug 2026
4 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20241 payment
- Celgene CorporationProgram year20241 payment
- Merck Sharp & Dohme LLCProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
41.7%Gabapentinoids10.7%Gabapentin100%Part D≥15 patientsOpioid Agonist6.3%Tramadol Hcl77%Fentanyl23%Part D<11 patientsMetabolism & gastrointestinal
22.6%Corticosteroid11.7%Prednisone100%Part D≥18 patientsProton pump inhibitor4.5%Pantoprazole Sodium60%Omeprazole40%Part D<11 patientsCancer & immunology
10.5%Nonsteroidal Anti-inflammatory Drug6.3%Celecoxib100%Part D≥13 patientsFolate Analog Metabolic Inhibitor2.8%Methotrexate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
27 NIH research awards on record, funded 1991–2026 per NIH RePORTER. The latest:
- Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
Oklahoma Medical Research Foundation
FY2026$8,199,999UC2AR081032 - Oklahoma Shared Clinical and Translational Resources
University of Oklahoma Hlth Sciences Ctr
FY2026$3,999,999U54GM104938 - Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
Oklahoma Medical Research Foundation
FY2026$2,873,650UC2AR081032
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinical, Histologic, and Serological Predictors of Renal Function Loss in Lupus Nephritis.
Arthritis care & research
Article2026 - Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment.
Arthritis care & research
Article2026 - A Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Incomplete Lupus.
Arthritis & rheumatology (Hoboken, N.J.)
Clinical Trial2026 - A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis.
Arthritis & rheumatology (Hoboken, N.J.)
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Judith-James-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/profile/Judith-James-3
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- M.D.
University of Oklahoma Health Sciences Center / College of Medicine (inaugural MD/PhD class)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗ - B.S. in Chemistry (minors in Math and Music)
Oklahoma Baptist University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗
Editorial & leadership roles
journal and society appointments- Chair
Arthritis & Clinical Immunology Research Program, OMRF
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗ - Member
NIAID Autoimmunity Centers of Excellence
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Member
National Academy of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗
- Professor of Medicine and Pathology; Associate Vice Provost for Clinical & Translational Science
University of Oklahoma Health Sciences Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗
Media & interviews
press, podcasts and appearances- Extensive OMRF newsroom media coverage (2014-2026) on lupus research
autoimmune disease prevention trials, and clinical findings
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗ - "Dr. Everything" feature profile
OMRF Findings
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nimhd.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Joan Merrill, MD
Oklahoma Medical Research Foundation
Eliza Chakravarty, MD
Oklahoma Medical Research Foundation
Gary Kinasewitz, MD
Oklahoma Medical Research Foundation
Gabriel Pardo, MD
Oklahoma Medical Research Foundation